MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target...

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Invasive ductal carcinoma (IDC) is the most prevalent form of breast cancer.
• Early-stage detection significantly improves patient prognosis.
• MicroRNAs (miRNAs) show promise as diagnostic and prognostic tools for breast cancer.

Purpose of the Study:

• To develop a cost-effective, rapid, and robust protocol for early breast cancer detection using miRNA signatures.
• To identify reliable miRNA biomarkers for classifying different types, grades, and stages of IDC.
• To elucidate the role of miRNAs in breast cancer development and progression.

Main Methods:

• Analysis of miRNA signatures in 100 breast cancer samples using two array systems.
• Validation of miRNA signatures via TaqMan assays, tissue microarrays, and northern analysis.
• In silico target prediction and validation using q-PCR, immunoblotting, and antibody arrays.

Main Results:

• Identified 107 potential miRNA biomarkers for IDC stratification from 439 associated miRNAs.
• Revealed extensive miRNA networks involved in oncogenic pathways, including epithelial-mesenchymal transition (EMT).
• Confirmed common miRNA signatures between human samples and Brca2/p53 mouse models.

Conclusions:

• The study presents potential biomarkers for robust classification and early detection of IDC.
• Findings confirm miRNA involvement in cancer development and highlight their role in EMT and cellular plasticity.
• The identified miRNA signatures offer new insights for IDC classification and early diagnosis.